---
schema_version: "secwatch.filing_event.v1"
accession: "0001725160-25-000127"
form_type: "8-K"
ticker: "ZNTL"
cik: "0001725160"
company_name: "Zentalis Pharmaceuticals, Inc."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:10:54.539617+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Zentalis shareholders elect three directors, approve auditor and say-on-pay at annual meeting

## Summary
- Scott Myers (43.0M for), Karan Takhar (30.7M for), and Luke Walker (36.6M for) elected as Class II directors.
- Ratification of Ernst & Young as auditor approved with 58.1M votes for (over 99.9% of votes cast).
- Advisory say-on-pay passed with 29.5M for vs 17.4M against (~63% of votes cast excluding broker non-votes).
- Total 58.2M shares voted (80.9% of outstanding common stock as of April 21, 2025 record date).

## SEC filing metadata
- accession: 0001725160-25-000127
- form_type: 8-K
- ticker: ZNTL
- cik: 0001725160
- company_name: Zentalis Pharmaceuticals, Inc.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725160/000172516025000127/0001725160-25-000127-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725160/000172516025000127/zntl-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001725160-25-000127
- JSON: https://secwatch.observer/filing/0001725160-25-000127.json
- Plain text: https://secwatch.observer/filing/0001725160-25-000127.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.